Construction of Recombinant Over Expression Vector of PENK Gene and the Function Study of PENK Gene

MENG Fu-fen, WEI La, LIU Jia.et al

Abstract

To construct recombinant over expression vector of Homo sapiens proenkephalin (PENK) gene and explore the function of PENK gene. Methods Fragment containing PENK ORF gene was inserted into vector plasmid HIV, then the recombinant over was confirmed by enzyme digestion and sequencing. Lentivirus containing the recombinant over expression vector was produced by virus packaging with 293Ta cell，and then the lentivirus was transfected into HT1080 cell and the virus titer was estimated. The PC12 were tansfected with resulting lentivirus and un-transfected PC12 cells as control. The images of the PC12 cells were captured at 48 h post-transfection and the number of cells was also evaluated; the changes of PENK mRNA in transfection and control group were measured with RT-PCR. Results The constructed PENK ORF recombinant over expression vector was confirmed by enzyme digestion and sequencing. The number of PC12 cells in transfection and control group at 48 h post-transfection was 127.93±2.48 and 88.60±2.55 respectively, and the statistical difference between them was observed (P<0.01). Conclusion Recombinant over expression vector of PENK gene was successfully constructed and the PENK gene can promote the growth of PC12.

 

Keywords: PENK, Construct recombinant, Plasmid HIV 

 

Full Text:

PDF


References


Lewis RV, Stern AS. Biosynthesis of the enkephalins and enkephalin-containing polypeptides. Annu Rev Pharmacol Toxicol, 1983; 23:353-372.

Comb M. Rosen H. Seeburg P. et al. Primary structure of the human proenkephalin gene. DNA,1983;2(3);213-229.

Pittius CW. Seizinger HR. Mehraein P. et al. Proenkephalin- A-derived peptides are present in human brain. Life Sci,1983; 33( 1): 41 -44.

Imura H, Nakai Y, Nakao K. et al. Biosynthesis and distribution of opioid peptides. J Endocrinol Invest. 1983;6(2): 139-149.

Kojima K. Structure of proenkephalin. Tanpakushitsu Kakusan Koso,1983;28(6):815-833.

Gera G. Maremmani I.Capovani В, et al. Long-acting opioid- agonists in the treatment of heroin addiction: why should we call them, substitution’. Subst Use Misuse. 2009; 44 ( 5 ): 663- 671.

Glorioso JC, Fink DJ. Gene therapy for pain; introduction to the special issue. Gene Ther,2009; 16(4);453-454.

Federici T, Boulis N. Gene therapy for peripheral nervous systea diseases. Curr Gene Ther, 2007;7(4):239-248.

Pinto M, Castro AR.Tshudy F,et al. Opioids modulate pain facilitation from the dorsal reticular nucleus. Mol Cell Neu,2008;39(4):50.

Xu W.Sanz A. Pardo L,et al. Activation of the mu opioid re-ceptor involves conformational rearrangements of multiple transmembrane domains. Biochemistry, 2008; 47 (40 ); 10576 - 10586.

Lemos MV, Menezes H. The effect of an immune RNA (RNAi) against Тгуряпочотя Grim infprtion in mirp. Trop Med Parasitol, 1978; 29 ( 1); 119-126.

Gojobori T, Nei M. Inter-RNA homology and possible roles of small RNAs. J Mol Evol. 1981; 17(4) :245-250.

Harp PA. RNAi and double-strand RNA. Genes Dev,1999;13 (2) : 139-141.

Artemova N, Bumagina Z. Opioid peptides derived from food proteins suppress aggregation and promote reactivation of partly unfolded stressed proteins. Peptides,2009? 11(25):332- 338.

Sarkar DK,Zhang CQ, Murugan S, et al. Transplantation of beta-endorphin neurons into the hypothalamus promotes immune function and restricts the growth and metastasis of mammary carcinoma. Cancer Res, 2001;71 (19);6282-6291.

Karayiannakis AJ, Zbar A, Makri, et al. Serum beta- endorphin levels in morbidly obese patients; the effect of vertical banded gastroplasty. Eur Surg Res, 1998;30(6): 409- 413.

Seaki T, Nishimura M, Sato N, et al. Electrophysiological demonstration and activation of mu-opioid receptors in the rabbit sinoatrial node. J Cardiovasc Pharmacol, 1995; 26( 1 ); 160-168.


Refbacks

  • There are currently no refbacks.